NCT00389792 Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers Status COMPLETED Phase PHASE2
NCT00379301 Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation Status COMPLETED Phase NA
NCT00377702 Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups Status COMPLETED Phase N/A
NCT00376272 GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence Status COMPLETED Phase PHASE3
NCT00369330 KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation Status WITHDRAWN Phase NA
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial Status COMPLETED Phase NA
NCT00356759 Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients Status COMPLETED Phase PHASE2
NCT00356057 Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace Status TERMINATED Phase NA
NCT00354796 The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin Status UNKNOWN Phase N/A
NCT00352560 Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF) Status COMPLETED Phase PHASE3
NCT00343499 The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial) Status TERMINATED Phase PHASE4
NCT00340314 A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF) Status COMPLETED Phase PHASE4
NCT00338715 Effectiveness of Pulmonary Vein Isolation in Prevention of Atrial Fibrillation Following Heart Bypass Surgery Status COMPLETED Phase PHASE3
NCT00334464 A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study" Status COMPLETED Phase NA
NCT00321945 A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers Status COMPLETED Phase N/A
NCT00321802 Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins Status COMPLETED Phase PHASE2
NCT00321204 A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias Status TERMINATED Phase N/A
NCT00315068 Usefulness of Markers to Predict Recurrence of Atrial Fibrillation After Radiofrequency Catheter Ablation Status UNKNOWN Phase N/A